A recent clinical study [55] showed that a genetic variation in Cbr3 gene in humans correlates with type 2 diabetes and this effect can potentially be attributed to the catalysis of the conversion of prostaglandin E2 to prostaglandin F2α. This evidence concerns the gene CBR3 and type 2 diabetes mellitus.